Device
Cardiac Contractility Modulation (CCM)
Cardiac Contractility Modulation (CCM) is a medical device with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
unknown133%
recruiting267%
Recent Activity
2 active trials
Showing 3 of 3
recruiting
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
NCT07209098
recruitingnot_applicable
Cardiac Contractility Modulation in Chagas Heart Disease
NCT05519046
unknown
Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure
NCT05167799
Clinical Trials (3)
Showing 3 of 3 trials
NCT07209098
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
NCT05519046Not Applicable
Cardiac Contractility Modulation in Chagas Heart Disease
NCT05167799
Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3